Committees

Science Advisory Committee 

William Foulkes (Chair)

McGill Centre for Translational Research in Cancer, Canda

Rachel Butler 

North Bristol NHS Trust
Majorlijn Ligtenberg

Radboud University Medical Center, Netherlands
Mary Porteous

University of Edinburgh

Our Science Advisory Committee consists of four independent members drawn from leading scientists broadly representing the programme diversity.

The committee meet annually, along with CRUK and PPI representation, to monitor progress and provide scientific evaluation of the CGCV program of research to the programme and work-package leads. The feedback received from the SAC is used to direct future research and program strategy.

Patient Reference Panel

Lesley Turner (Chair)

Independent Cancer Patient Voices

 

Further members TBA 

The Patient Reference Panel (PRP) will be made up of 'research partners': patients, carers and members of the public who are affected by cancer and have an interest in genetics. 

The PRP has been set up to for our research partners, working together with our research team, to look at how the CanGene-CanVar programme is set up and running, to make sure it is in the best interests of those who may be considering genetic testing, as well as making sure of good research outcomes. 

CanVIG Steering and Advisory Committee (CStAG)

Alison Calloway (Co-Chair)

Salisbury NHS Foundation Trust

Miranda Durkie (Co-Chair)

Sheffield University Hospitals NHS Foundation Trust

Rachel Robinson

Leeds Teaching Hospitals NHS Trust
George Burghel

Manchester University NHS Foundation Trust
James Drummond

Cambridge University Hospitals NHS Trust
Ian Berry

Leeds Teaching Hospitals NHS Trust 
Andrew Wallace

Manchester University NHS Foundation Trust

CStAG is formed of NHS Clinical Laboratory Scientist representatives from across the UK. 

The committee has been established from members of CanVIG, a group formed to improve the consistency of cancer genetic variant interpretation in the UK. The members are focussing the working priorities of CanVIG-UK and are an expert group of advisors supporting work-package 2

02087224626

  • Twitter Clean

@CangeneCanvar

This work was supported by Cancer Research UK [C61296/A27223]